Skip to search formSkip to main contentSkip to account menu

International Germ Cell Consensus Classification

Known as: IGCCG 
A staging system for metastatic malignant germ cell tumors developed by the International Germ Cell Cancer Collaborative Group. It is a factor-based… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Incorporating age into International Germ Cell Consensus Classification (IGCCC): a time to move forward?
ABSTRACT Background: Older age is a poor prognostic indicator among patients with germ cell tumors. The current study evaluates… 
2015
2015
Is the International Germ Cell Consensus Classification (IGCCC) sufficiently predictive in 2015
387 Background: The IGCCC has been an invaluable tool to guide clinical trial development in disseminated germ cell tumors. This… 
Review
2011
Review
2011
Suboptimal survival of male germ-cell tumors in southern Portugal--a population-based retrospective study for cases diagnosed in 1999 and 2000.
BACKGROUND The outcome of germ-cell tumors (GCTs) is a hallmark of good-quality cancer care. In the Eurocare-4 study, the mean 5… 
2008
2008
Stage migration and pilot studies of reduced chemotherapy supported by positron‐emission tomography findings suggest new combined strategies for stage 2 nonseminoma germ cell tumour
To examine the nodal (N+) vs extranodal (M+) staging in each of the International Germ Cell Consensus Classification Group… 
2007
2007
Poor-prognosis germ cell tumors: we have not yet crossed the finish line.
During the 2006 meeting of the American Society of Clinical Oncology, Lance Armstrong received the Special Recognition Award for… 
Review
2006
Review
2006
Treatment of germ cell tumors--update 2006.
Testicular cancer is considered a malignancy with a high cure rate even in patients with metastatic disease. Treatment strategies… 
Review
2005
Review
2005
The management and outcome of patients with germ-cell tumours treated in the Edinburgh Cancer Centre between 1988 and 2002.
Review
2004
Review
2004
Early identification of therapeutic failure in nonseminomatous germ cell tumors by assessing serum tumor marker decline during chemotherapy: still not ready for routine clinical use.
Serum tumor markers play a vital role in the excellent outcomes now expected for men with testicular cancer. The relative… 
2001
2001
Germ cell tumors in patients infected by the human immunodeficiency virus
The objective of this study was to assess the natural history of the two disease courses, patient immune system tolerance, and… 
2000
2000
Risk-Adapted Chemotherapy of Germ Cell Tumors with Carboplatin, Etoposide and Bleomycin for Low-Risk and Cisplatin, Etoposide and Ifosfamide for High-Risk Patients
The prognosis of germ cell tumors treated with chemotherapy depends on the presence of nonseminomatous tumor, clinical parameters… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)